[Disease management from the economic point of view].

Autor: Oberender P; Universität Bayreuth, Lehrstuhl für Volkswirtschaftslehre-Wirtschaftstheorie-, Forschungsstelle für Sozialrecht und Gesundheitsökonomie, Bayreuth. vw14@uni-bayreuth.de, Zerth J
Jazyk: němčina
Zdroj: Zeitschrift fur arztliche Fortbildung und Qualitatssicherung [Z Arztl Fortbild Qualitatssich] 2003 Jun; Vol. 97 (3), pp. 189-94.
Abstrakt: The introduction of disease management programs for chronic diseases aims to achieve a permanent improvement of care. Such an improvement cannot be reached without effective incentives. However, the incentives set in the German Health Care System may cause reactions on the micro level that do not correspond to the aims on the macro level. In the long term, patient empowerment will be needed in order to enable a shared-decision-making of patients and physicians. A market-oriented solution consists of quality competition allowing for various delivery systems and the search for new models that lead to an improvement of care. However, quality competition will have to respect the traditional principle of solidarity underlying the German health care system. Disease management will contribute to an integrated, incentive-oriented delivery system but only if it allows for a variety of care.
Databáze: MEDLINE